0

Glycomics Market: Current Analysis and Forecast (2021-2027)

Region:Global

Author(s):

Product Code:UMHE21325

Download Sample Report download
Buy the Full ReportStarting from $3500
Published on

July 2021

Total pages

152

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $3500

About the Report

About the Report

Glycomics is a subset of the glycobiology field that deals in identifying the structure and function of the complete set of the glycome produced in a particular cell or organism and identify all the genes that encode glycoproteins. It is one of the rapidly emerging research fields highlighting functional aspects of glycans in biological systems. With rapid technological advancement and rising investment in research & development among pharmaceutical & biotechnology companies, the glycomics market is witnessing an uptick globally. For instance, The Pharmaceutical Research and Manufacturers of America (PhRMA) trade group represents the leading biopharmaceutical research companies in the United States. In 2019, the research and development (R&D) expenditure of its member companies reached USD 83 billion worldwide, up from USD 79.6 billion in 2018. Furthermore, the growing focus on Glycomics research owing to its wide scope of applications in drug discovery and development and other varied segments is propelling the growth of this market. The glycomics market is growing exponentially on account of growth in mortality rates and incidences of cancer and other chronic diseases coupled with the heavy demand for medicines across the world. For instance, according to the World Health Organization, cancer is one of the leading causes of death globally, accounting for nearly 9.6 million deaths in 2018. this number has reached around 10 million deaths globally in 2020. Therefore, scientists across the world are carrying out high-level research on cancer therapeutics and diagnostics including research on glycomic biomarkers as many recent studies suggest that glycan structure correlates with cancer development.

Based on product, the market is fragmented into enzymes, kits, instruments, reagents, and others. The enzyme segment generated revenue of USD XX million in 2020. The segment is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX million by 2027F owing to the growing use of enzymes in cancer research. Based on the application, the market is fragmented into diagnostics, drug discovery and development, and others. The drug discovery and development segment dominated the market and generated revenue of USD XX million in 2020 owing to the rising potential of glycomics in the identification of biomarkers and increase in demand for glycomics products in drug discovery & development.

The glycomics research and development and utilization are available at various centers including pharmaceutical & biotechnology companies, academic research institutes, clinical research laboratories, and others. The academic research institute segment is anticipated to dominate the market during the analyzed period and reach USD XX million by 2027F. However, the pharmaceutical & biotechnology companies segment is also anticipated to grow at the highest CAGR during the projected timeframe.

For a better understanding of the market adoption of the glycomics, the market is analyzed based on its worldwide presence in the countries such as North America (United States and Canada), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), and Rest of World. North America constitutes a major market for the glycomics industry and generated revenue of USD XX million in 2020 owing to the increasing incidence of cancer and other diseases and increasing funding for R&D related to glycomics in the region. Some of the major players operating in the market include Thermo Fisher Scientific, Agilent Technologies, Danaher, Merck KGaA, RayBiotech, Shimadzu Corporation, Takara Bio, New England Biolabs, S-BIO, Waters Corporation, etc. Several M&A's along with partnerships have been undertaken by these players to develop new and advanced Glycomics tools.

Products


Companies

Thermo Fisher Scientific, Agilent Technologies, Danaher, Merck KGaA, RayBiotech, Shimadzu Corporation, Takara Bio, New England Biolabs, S-BIO, Waters Corporation

Table of Contents

Table of Contents

1 MARKET INTRODUCTION

1.1 Market Definitions

1.2 Objective of the Study

1.3 Limitation

1.4 Stake Holders

1.5 Currency Used in Report

1.6 Scope of the Global Glycomics Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1 Research Methodology for the Global Glycomics Market

2.1.1 Main Objective of the Global Glycomics Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 COVID-19 IMPACT

6 GLOBAL GLYCOMICS MARKET REVENUE

7 MARKET INSIGHTS BY PRODUCT

7.1 Enzymes

7.1.1 Glycosidases

7.1.2 Glycosyltransferases

7.1.3 Neuraminidases

7.1.4 Sialyltransferases

7.1.5 Others

7.2 Instruments

7.2.1 HPLC

7.2.2 MALDI-TOF

7.2.3 Mass Spectrometers

7.2.4 Array Systems

7.2.5 Others

7.3 Kits

7.3.1 Glycan Labeling Kits

7.3.2 Glycan Purification Kits

7.3.3 Glycan Release Kits

7.3.4 Others

7.4 Reagents

7.4.1 Glycoproteins

7.4.2 Monosaccharides

7.4.3 Oligosaccharides

7.4.4 Others

7.5 Others

8 MARKET INSIGHTS BY APPLICATION

8.1 Diagnostics

8.2 Drug Discovery & Development

8.3 Others

9 MARKET INSIGHTS BY END-USERS

9.1 Pharmaceutical & Biotechnology Companies

9.2 Academic Research Institutes

9.3 Clinical Laboratories

9.4 Others

10 MARKET INSIGHTS BY REGION

10.1 NORTH AMERICA GLYCOMICS MARKET

10.1.1 United States

10.1.2 Canada

10.1.3 Rest of North America

10.2 EUROPE GLYCOMICS MARKET

10.2.1 Germany

10.2.2 France

10.2.3 United Kingdom

10.2.4 Spain

10.2.5 Italy

10.2.6 Rest of Europe

10.3 ASIA PACIFIC GLYCOMICS MARKET

10.3.1 China

10.3.2 Japan

10.3.3 India

10.3.4 Australia

10.3.5 Rest of Asia Pacific

10.4 REST OF THE WORLD GLYCOMICS MARKET

11 GLYCOMICS MARKET DYNAMICS

11.1 Market Drivers

11.2 Market Challenges

11.3 Impact Analysis

12 GLYCOMICS MARKET OPPORTUNITIES

13 GLYCOMICS MARKET TRENDS & INSIGHTS

14 LEGAL & REGULATORY FRAMEWORK

15 DEMAND AND SUPPLY SIDE ANALYSIS

15.1 Demand Side Analysis

15.2 Supply Side Analysis

15.2.1 Top Product Launches

15.2.2 Top Business Partnerships

15.2.3 Top Merger & Acquisitions

16 VALUE CHAIN ANALYSIS

17 COMPETITIVE SCENARIO

17.1 Porter's Five forces analysis

17.1.1 Bargaining power of Supplier

17.1.2 Bargaining power of Buyer

17.1.3 Industry Rivalry

17.1.4 Availability of Substitute

17.1.5 Threat of new Entrants

18 COMPANY PROFILED

18.1 Agilent Technologies

18.1.1 Key Facts

18.1.2 Business Description

18.1.3 Key Product/Services Offerings

18.1.4 Growth Strategy

18.1.5 SWOT Analysis

18.1.6 Key Financials

18.1.6.1 Revenue Split

18.1.6.2 Financial Overview of Agilent Technologies

18.1.7 Recent Developments

18.1.7.1 Product Launch

18.1.7.2 Partnerships

18.1.7.3 Business Expansion and Investments

18.1.7.4 Merger and Acquisition

18.2 Thermo Fisher Scientific

18.3 Danaher

18.4 Merck KGaA

18.5 RayBiotech

18.6 Shimadzu Corporation

18.7 Takara Bio

18.8 S-BIO

18.9 New England Biolabs

18.10 Waters Corporation

19 DISCLAIMER

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022